Genetic dissection of stool frequency implicates vitamin B1 metabolism and other actionable pathways in the modulation of gut motility - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Genetic Analysis of Stool Frequency Reveals Involvement of Vitamin B1 Metabolism and Other Targetable Pathways in Gut Motility Regulation

  • By

  • Cristian Díaz-Muñoz

  • Isotta Bozzarelli

  • Esteban Alexander Lopera-Maya

  • Lazaros Belbasis

  • Valeria Lo Faro

  • Leticia Camargo Tavares

  • Francisco Heredia-Fernández

  • Biagio Di Lorenzo

  • Trishla Sinha

  • Cristina Esteban Blanco

  • Marie-Julie Favé

  • Philip Awadalla

  • Robin G Walters

  • Ferdinando Bonfiglio

  • Alexandra Zhernakova

  • Serena Sanna

  • Mauro D’Amato

  • August 1, 2026

Share

Clinical Scorecard: Genetic Analysis of Stool Frequency Reveals Involvement of Vitamin B1 Metabolism and Other Targetable Pathways in Gut Motility Regulation

At a Glance

CategoryDetail
ConditionGut Motility Regulation
Key MechanismsVitamin B1 metabolism, bile acid and cholinergic signalling
Target PopulationIndividuals with IBS and functional constipation
Care SettingPopulation-based biobank surveys

Key Highlights

  • Stool frequency is partially heritable and shares genetic architecture with gastrointestinal, psychiatric, and cardiovascular traits.
  • Causal inference analyses implicate actionable pathways affecting IBS.
  • Fine-mapping identified SLC35F3 and XPR1 as key loci related to vitamin B1 metabolism.
  • Dietary vitamin B1 intake is strongly associated with stool frequency.
  • Findings support the use of stool frequency as an endophenotype for genetic discovery in IBS.

Guideline-Based Recommendations

Diagnosis

  • Utilize stool frequency as a proxy for gut motility in IBS assessment.

Management

  • Consider targeting thiamine metabolism and other modifiable pathways for personalized interventions.

Monitoring & Follow-up

  • Monitor stool frequency as a measure of gut motility in clinical settings.

Risks

  • Alterations in gut motility can lead to IBS and other disorders of gut-brain interaction.

Patient & Prescribing Data

Individuals with IBS and functional constipation

Potential for personalized nutritional or pharmacological interventions targeting gut motility.

Clinical Best Practices

  • Incorporate genetic insights into the understanding of gut motility mechanisms.
  • Utilize endophenotypes like stool frequency for genetic studies in IBS.

Related Resources & Content

Original Source(s)

Related Content